Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06458127 · ClinicalTrials.gov registry record · NA
Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease
A NA study of Chronic Graft Versus Host Disease and cGVHD, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06458127: Active NA study of Chronic Graft Versus Host Disease and cGVHD, sponsored by Massachusetts General Hospital.
NCT06458127 is a NA study of Chronic Graft Versus Host Disease and cGVHD that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 10 participants, below the 116-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06458127, a NA study of Chronic Graft Versus Host Disease and cGVHD, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is evaluating the feasibility and acceptability of implementing a telehealth palliative care intervention in patients with moderate to severe chronic graft-versus-host disease.
Primary Outcome
To calculate the feasibility of the intervention using the proportion of eligible patients who are approached and agree to participate, with 95% confidence interval. The intervention will be deemed feasible if at least 60% of patients with moderate to severe cGVHD agree to participate in the study.
Conditions Studied
Interventions
- OTHER Tele-palliative care visit
Study Locations (1)
Massachusetts
- Massachusetts General Hospital (MGH) - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
What the registry record for NCT06458127 still lists
NCT06458127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 116-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Chronic Graft Versus Host Disease appearing as the primary indexed condition, and to 1 intervention - of which Tele-palliative care visit is the first listed.
NCT06458127 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06458127 about?
NCT06458127 is a clinical study titled "Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease". This research study is evaluating the feasibility and acceptability of implementing a telehealth palliative care intervention in patients with moderate to severe chronic graft-versus-host disease.
What is the current status of trial NCT06458127?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-09-09. Estimated completion is 2027-01-30.
What conditions does trial NCT06458127 study?
This clinical trial studies the following conditions: Chronic Graft Versus Host Disease, cGVHD, Chronic GVHD.
What interventions are being tested in trial NCT06458127?
The interventions under investigation include: Tele-palliative care visit (OTHER).
Who is sponsoring clinical trial NCT06458127?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06458127 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Graft Versus Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06458127's enrollment target sits among peer trials
10 30th of 30 higher than 1 of 30 other Chronic Graft Versus Host Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Graft Versus Host Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
RECRUITING · NA
-
Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease
ACTIVE NOT RECRUITING · NA
-
Psychosocial Mobile App for Chronic Graft-Versus-Host Disease
ACTIVE NOT RECRUITING · NA
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
A Long-term Extension Study of PCI-32765 (Ibrutinib)
RECRUITING · Phase 3
-
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI